arrow
D

D. CHIANELLI

Novartis
H指数:22
被引数:1,826

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Antitarget Selectivity and Tolerability of Novel Pyrrolo[2,3-d]pyrimidine RET Inhibitors
2021-11-065
OA
Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases
2020-07-1566
OAAI
Efficacy and Tolerability of Pyrazolo[1,5-a]pyrimidine RET Kinase Inhibitors for the Treatment of Lung Adenocarcinoma

吡唑并 [1,5-a] 嘧啶RET激酶抑制剂治疗肺腺癌的疗效和耐受性

2020-02-1218
OAAI
Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis

Ndufexor (LMB763),一种用于治疗非酒精性脂肪性肝炎的新型FXR调节剂

2020-01-1585
OAAI
Tropifexor-Mediated Abrogation of Steatohepatitis and Fibrosis Is Associated With the Antioxidative Gene Expression Profile in Rodents
2019-05-1780
OAAI
Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH)
2017-12-08209
OA